Letters to the editorSwitching from insulin glargine to insulin degludec reduced HbA1c, daily insulin doses and anti-insulin antibody in anti-insulin antibody-positive subjects with type 1 diabetes
Section snippets
Disclosure of interest
The authors declare that they have no conflicts of interest concerning this article.
References (5)
- et al.
Basal insulin analogs: from pathophysiology to therapy. What we see, know, and try to comprehend?
Diabetes Metab
(2013) Insulin degludec and insulin degludec/insulin aspart: a review of their use in the management of diabetes mellitus
Drugs
(2013)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2014 Elsevier Masson SAS. All rights reserved.